Exane Derivatives’s Apple AAPL Stock Holding History

Exane Derivatives’s Portfolio AAPL Stock Details AAPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,000	Closed	-$436K	–	568
2016 Q4	$436K	Hold	4,000	–	–	0.09%	168
2016 Q3	$570K	Buy	+4,000	New	+$106K	0.09%	145
2016 Q2	–	Sell	-5,200	Closed	-$1.04M	–	549
2016 Q1	$1.04M	Buy	+5,200	New	+$130K	0.14%	86
2015 Q4	–	Sell	-1,000	Closed	-$171K	–	501
2015 Q3	$171K	Buy	+1,000	New	+$29.3K	0.02%	196

Other funds holding AAPL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Exane Derivatives's AAPL Position: Q2 2022 in Review

Exane Derivatives sold out of Apple (AAPL) in Q2 2022, closing a stake of 18,614 shares — an estimated $3.25M sold.

Exane Derivatives first reported a position in AAPL in Q4 2014 and held it in 18 quarters. The position peaked at $6.66M in Q2 2016. 4,326 funds tracked by Wall St. Rank hold AAPL as of Q2 2022.

Exane Derivatives reported no remaining Apple position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 18,614 Apple shares in Q2 2022, an estimated $3.25M.
Exane Derivatives first reported a position in Apple in Q4 2014 and held it in 18 quarters.
Exane Derivatives's Apple position peaked at $6.66M in Q2 2016.
4,326 funds tracked by Wall St. Rank held Apple as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.